AIG
KLRS

American International Group’s Kalaris Therapeutics KLRS Stock Holding History

American International Group’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50,173
Closed -$19.8K – 2856
2024
Q1 		$19.8K Sell
50,173
-9
-0% -$147 ﹤0.01% 2932
2023
Q4 		$785K Sell
50,182
-5
-0% -$197 ﹤0.01% 1430
2023
Q3 		$2.48M Buy
50,187
+228
+0.5% +$15.5K 0.02% 893
2023
Q2 		$3.91M Buy
49,959
+225
+0.5% +$21.4K 0.02% 806
2023
Q1 		$4.51M Buy
49,734
+13
+0% +$1.66K 0.03% 763
2022
Q4 		$5.87M Sell
49,721
-2
-0% -$339 0.04% 634
2022
Q3 		$9.02M Buy
49,723
+9
+0% +$1.4K 0.07% 366
2022
Q2 		$4.46M Sell
49,714
-5
-0% -$524 0.03% 743
2022
Q1 		$7.72M Sell
49,719
-45
-0.1% -$8.98K 0.04% 593
2021
Q4 		$14.8M Sell
49,764
-20
-0% -$9.28K 0.07% 286
2021
Q3 		$28.7M Buy
49,784
+6,070
+14% +$2.81M 0.15% 102
2021
Q2 		$19.8M Sell
43,714
-31
-0.1% -$16K 0.07% 229
2021
Q1 		$23.5M Buy
43,745
+4,162
+11% +$3.5M 0.08% 178
2020
Q4 		$35M Buy
39,583
+39,117
+8,394% +$30.1M 0.13% 120
2020
Q3 		$295K Buy
+466
New +$318K ﹤0.01% 1897

Other funds holding KLRS

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American International Group's KLRS Position: Q2 2024 in Review

American International Group sold out of Kalaris Therapeutics (KLRS) in Q2 2024, closing a stake of 50,173 shares — an estimated $19.8K sold.

American International Group first reported a position in KLRS in Q3 2020 and held it in 15 quarters. The position peaked at $35M in Q4 2020. 71 funds tracked by Wall St. Rank hold KLRS as of Q2 2024.

  • American International Group reported no remaining Kalaris Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 50,173 Kalaris Therapeutics shares in Q2 2024, an estimated $19.8K.
  • American International Group first reported a position in Kalaris Therapeutics in Q3 2020 and held it in 15 quarters.
  • American International Group's Kalaris Therapeutics position peaked at $35M in Q4 2020.
  • 71 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.